Related Experiment Video
Updated: Feb 27, 2026

Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System
Published on: November 22, 2016
Aggregate Consumer Exposure and Risk Assessment in the EU-A Case Study
Jan Oltmanns1, Christoph Scheibelein2, Fabian A Grimm3
1Forschungs- und Beratungsinstitut Gefahrstoffe GmbH (FoBiG), Klarastraße 63, 79106 Freiburg, Germany.
Abstract:
Consumer exposure to chemicals in the EU is currently assessed separately for different products without aggregating exposure from different sources. A more integrated ap proach represents a promising opportunity to improve comprehensive risk evaluation and transparency across the value chain. This study develops aggregate consumer expo sure and risk assessment methods that involve calculation of exposure and risk for each pathway using the risk characterization ratio (RCR) as a uniform risk metric. Aggregate risk is obtained by adding up pathway-specific RCRs. The developed methodology re presents a new approach by evaluating exposure of seven population groups via all path ways and by using key input values normalized to body weight to reflect population-specific differences. The study demonstrates the practical applicability of the methodol o gy by assessing consumer exposure to the antioxidant ethylene bis[3,3-bis(3-tert-butyl-4-hydroxyphenyl)butyrate] (Hostanox® O 3), resulting from its use in food and drinking water contact materials, textiles and sealants. This case study demonstrates aggregate RCRs well below one for all groups. The highest aggregate RCRs are found for infants and toddlers, reflecting their proportionally higher food consumption and skin surface area. The methodology is transparent and can easily be applied to other substances, e.g., by industry stakeholders and authorities, if the substance concentration in products can be established. This study may inform further development of aggregate exposure and risk methods in EU regulatory frameworks.
More Related Videos
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Relative Risk
Toxicity Testing in Animals

